信函：在SARS-CoV-2社区传播活跃时，新冠病毒病（COVID-19）模拟炎症性肠病（IBD）发作的频率有多高？
Letter: how frequently does COVID-19 mimic an IBD flare when community transmission of SARS-CoV-2 is active?
作者信息
O'Morain Neil, Coe Carolann, Mallon Patrick, Twomey Patrick, De Gascun Cillian F, Doherty Glen A
机构信息
Centre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Department of Infectious Disease, St. Vincent's University Hospital, Dublin, Ireland.
出版信息
Aliment Pharmacol Ther. 2021 Mar;53(5):674-675. doi: 10.1111/apt.16240.
Abstract
This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804
摘要
本文与塔索内拉等人的论文相关联。要查看本文，请访问https://doi.org/10.1111/apt.15804
相似文献
1
Letter: how frequently does COVID-19 mimic an IBD flare when community transmission of SARS-CoV-2 is active?信函：在SARS-CoV-2社区传播活跃时，新冠病毒病（COVID-19）模拟炎症性肠病（IBD）发作的频率有多高？
Aliment Pharmacol Ther. 2021 Mar;53(5):674-675. doi: 10.1111/apt.16240.
2
Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.雾化吸入在炎症性肠病管理中的应用：新冠疫情期间炎症性肠病发作的一个罕见病例
Inflamm Bowel Dis. 2020 Sep 18;26(10):e128-e129. doi: 10.1093/ibd/izaa184.
3
Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.致编辑的信的回复：炎症性肠病患者中新冠病毒病的发病率和结局：快速综述与荟萃分析
Inflamm Bowel Dis. 2020 Sep 18;26(10):e127. doi: 10.1093/ibd/izaa172.
4
IBD in the Times of COVID-19.新冠疫情时代的炎症性肠病
Inflamm Bowel Dis. 2020 Jul 17;26(8):e92. doi: 10.1093/ibd/izaa132.
5
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.COVID-19 大流行期间和大流行后期的炎症性肠病内镜检查。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606. doi: 10.1016/S2468-1253(20)30119-9. Epub 2020 Apr 16.
6
Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever.社论：2019冠状病毒病大流行期间的社交距离——炎症性肠病患者不能永远居家
Aliment Pharmacol Ther. 2020 Aug;52(4):717-718. doi: 10.1111/apt.15874.
7
Letter: IBD nurse-a pivotal role in the time of the pandemic.信：炎症性肠病护士——疫情时代的关键角色。
Aliment Pharmacol Ther. 2020 Aug;52(4):745. doi: 10.1111/apt.15905.
8
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era.新冠疫情后时代炎症性肠病的无创监测
Dig Liver Dis. 2020 Nov;52(11):1236-1237. doi: 10.1016/j.dld.2020.07.014. Epub 2020 Jul 19.
9
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply.信件：炎症性肠病护士在疫情期间的关键作用。作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(4):746-747. doi: 10.1111/apt.15954.
10
Prevention of COVID-19 in patients with IBD.炎症性肠病患者的新型冠状病毒肺炎预防
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):639-640. doi: 10.1016/S2468-1253(20)30153-9. Epub 2020 May 20.
本文引用的文献
1
Letter: SARS-CoV-2-induced gastrointestinal inflammation.信件：SARS-CoV-2 诱导的胃肠道炎症。
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1748-1749. doi: 10.1111/apt.16087.
2
2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.2019 新型冠状病毒病（COVID-19）合并炎症性肠病患者。
Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. doi: 10.1111/apt.15804. Epub 2020 Jun 7.
3
Faecal calprotectin indicates intestinal inflammation in COVID-19.粪便钙卫蛋白提示新冠病毒感染患者存在肠道炎症。
Gut. 2020 Aug;69(8):1543-1544. doi: 10.1136/gutjnl-2020-321388. Epub 2020 Apr 20.
4
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.综述文章：COVID-19 的胃肠道特征和粪便传播的可能性。
Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
5
Covid-19 and the digestive system.Covid-19 与消化系统。
J Gastroenterol Hepatol. 2020 May;35(5):744-748. doi: 10.1111/jgh.15047. Epub 2020 Apr 19.
6
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
7
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
8
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.炎症性肠病患者中铟 - 111标记的粒细胞粪便排泄与粒细胞标记蛋白钙卫蛋白之间的相关性。
Scand J Gastroenterol. 1999 Jan;34(1):50-4. doi: 10.1080/00365529950172835.
Zotero 插件